Jump Financial, LLC Autolus Therapeutics PLC Transaction History

Jump Financial, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.38 - $4.69 $717,553 - $995,658	-212,294 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$3.33 - $5.68 $622,024 - $1.06 Million	186,794 Added 732.53%	212,294 $738,000
Q1 2024 May 13, 2024	SELL	$5.39 - $7.29 $693,498 - $937,960	-128,664 Reduced 83.46%	25,500 $162,000
Q4 2023 Oct 21, 2024	SELL	$2.13 - $6.63 $123,816 - $385,401	-58,130 Reduced 27.38%	154,164 $992,000
Q4 2023 Feb 07, 2024	BUY	$2.13 - $6.63 $328,369 - $1.02 Million	154,164 New	154,164 $992,000
Q4 2021 Feb 10, 2022	SELL	$5.1 - $7.0 $336,090 - $461,300	-65,900 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.32 - $7.37 $99,191 - $137,413	18,645 Added 39.46%	65,900 $432,000
Q2 2021 Aug 13, 2021	BUY	$4.78 - $7.96 $131,258 - $218,581	27,460 Added 138.72%	47,255 $314,000
Q1 2021 May 17, 2021	BUY	$5.49 - $9.36 $108,674 - $185,281	19,795 New	19,795 $113,000

104

163M

2.8K

13.4K

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $280M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.